STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. LXEO
  4. [EFFECT] Lexeo Therapeutics, Inc. SEC Filing

[EFFECT] Lexeo Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 4:00 P.M.
Form: S-3
CIK: 0001907108
Company Name: Lexeo Therapeutics, Inc.
File Number: 333-288025

Source: View Original Filing on SEC EDGAR

Stock LXEO logo
Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

#3230 Ranked by Market Cap
N/A Ranked by Dividends

LXEO Latest News

Dec 4, 2025
Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum
Nov 5, 2025
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Oct 20, 2025
Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
Oct 16, 2025
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
Oct 16, 2025
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

LXEO Latest SEC Filings

Nov 20, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Nov 20, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Nov 20, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Nov 20, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
Nov 20, 2025
[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity

LXEO Stock Data

607.25M
68.04M
0.53%
89.37%
9.69%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW YORK